ValueWalk Contributor
The author of this article is a contributor to ValueWalk.com. ValueWalk is your everyday source of breaking and evergreen news on everything hedge funds and value investing.
ValueWalk Contributor's Latest Posts
7 Tips To Grow Your Wealth Like The Best Dividend Investors
Dividend investing is one of the most actionable, repeatable methods of building wealth over time. Fortunately, there are many resources available to learn about dividend investing. Many of them are published by some of the most successful dividend investors in the business. These include books, websites, and even shareholder letters. One particular example is the portfolios of […]
The Last Thing America Needs Is A Reignited War On Marijuana
The marijuana legalization movement has been holding its breath, waiting to see how President Donald Trump will address the issue. Public opinion and state law have leaned heavily in favor of decriminalizing the controversial cannabis plant over the last several years, signaling the inevitable downfall of the government’s war on drugs. However, as numerous state […]
14 Dividend Growth Stocks Rewarding Shareholders With A Raise
Every week I go through the list of dividend increases, as part of my monitoring process. I monitor the dividend increases from companies I own, and for companies I may be interested in the future. I find it helpful to see companies that I have bought almost a decade ago, still delivering consistent annual increases. […]
Precious Metals v. Mining Stocks: What You Need To Know
Most readers of this column own (or plan to own) physical precious metals – gold and silver, perhaps even some platinum or palladium. They may also own mining stocks. But which category is “best”? It’s like asking, “What’s the most efficient exercise?” or “What’s the best fishing lure?” Truth be known, it’s really about what […]
Is Small Cap Strength Sustainable?
Small caps have surged since Election Day. As shown in Figure 1, the small cap Russell 2000 Index has outperformed the large cap S&P 500 by 8.1% since November 8, 2016. The relative strength has been driven by several election-related factors, including prospects for corporate tax reform, deregulation, and President-elect Donald Trump’s efforts to encourage […]
FutureFuel Would Make A Great Acquisition
One of the cheapest stocks in our All Investable – Deep Value Stock Screener is FutureFuel Corp. (NYSE:FF). FutureFuel is a leading manufacturer of diversified chemical products and biofuels. FutureFuel’s chemicals segment manufactures specialty chemicals for specific customers (“custom manufacturing”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom manufacturing product portfolio includes a laundry detergent […]
Market Impact Of A Trump Presidency
Donald Trump emerged as the winner last night of a hotly contested presidential campaign and will be inaugurated as the 45th president of the United States on Friday, January 20, 2017. The transition to a Republican presidency and Trump’s rejection of politics as usual, which drew so many voters, naturally lead to questions about his […]
Major Factors That Influence Gold Prices
Gold is a strong part of our economy, and we need to know more about it. The price of gold fluctuates, and many factors have to intervene for this to happen every day. We are going to talk a little bit about these factors so you can become a better investor down the road. Factors […]
Asset Based Analysis: Does It Work?
Asset based analysis is one of the oldest and most fundamental ways to determine the intrinsic value of a stock. Benjamin Graham strongly advocated for this approach in his 1934 book, Security Analysis. Furthermore, Graham consistently invested in stocks using asset-based analysis throughout his six decade career. The question is, does it still work? Relevant […]
Go Long Value, Rotate Out Of Growth Stocks
“Low interest rates have made it very cheap for companies to grow. Higher ROI will outperform when capital becomes more expensive.” David Poppe, Sequoia Fund’s CEO, on why value stocks have underperformed growth stocks. According to Renaissance Capital, there were 192 biotech IPOs in the past 5 years, raising more than $14.7 billion. Most of […]
